Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Incyte Corporation INCY

Healthcare  —  Biotechnology
123.20 (1.62) (1.30%) as of 29 Sep
Market cap
$26.1B
P/E
15.4×
S&P 500 Member Revenue Champion (10y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Incyte Corporation (INCY) Book value per share

Incyte Corporation's book value per share at the end of fiscal 2025 was 26.5×, up 59.0% from 16.6× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 31.7×. Over the past ten years it has ranged from 1.0× (fiscal 2015) to 26.5× (fiscal 2025) — the current reading is the highest in ten years. Incyte Corporation ranks 19th of 614 Biotechnology companies by book value per share.

Book value per share, annual

Annual

Period Book value per share Change
FY2025 26.5× 59.03%
FY2024 16.6× (28.27%)
FY2023 23.2× 17.89%
FY2022 19.7× 15.10%
FY2021 17.1× 42.83%
FY2020 12.0× (0.96%)
FY2019 12.1× 33.33%
FY2018 9.1× 13.77%
FY2017 8.0× 256.99%
FY2016 2.2× 134.28%

Quarterly

Period Book value per share Change
Jun 2026 31.7× 12.25%
Mar 2026 28.2× 6.55%
Dec 2025 26.5× 11.37%
Sep 2025 23.8× 10.56%
42 more quarters

Against its own ten years

Low 1.0× High 26.5×
Ten-year median 12.1×
Current reading's percentile 100

Book value per share against peers

Company Book value per share
BNTX BioNTech SE Sponsored ADR compare 81.5×
JAZZ Jazz Pharmaceuticals PLC compare 76.0×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 46.4×
INCY Incyte Corporation 31.7×
RPRX Royalty Pharma PLC compare 22.0×
ALNY Alnylam Pharmaceuticals, Inc. compare 10.1×
GMAB Genmab A/S Sponsored ADR compare 9.7×
ROIV Roivant Sciences Ltd. compare 6.8×
INSM Insmed, Inc. compare 3.5×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on INCY